Sample sizes for lesion magnetisation transfer ratio outcomes in remyelination trials for multiple sclerosis

Multiple Sclerosis and Related Disorders

Volumn 3, Issue 2, 2014, Pages 237-243

  Altmann, D R ^a,b   Button, T ^c   Schmierer, K ^a,d   Hunter, K ^a   Tozer, D J ^a   Wheeler Kingshott, C A ^a   Coles, A ^c   Miller, D H ^a  

^a University College London   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Magnetic resonance imaging; Magnetisation transfer ratio; Multiple sclerosis; Remyelination; Research design; Sample size

Indexed keywords

ARTICLE; EX VIVO STUDY; FEASIBILITY STUDY; HISTOGRAM; HUMAN; IN VIVO STUDY; LESION MAGNETISATION TRANSFER RATIO; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; REMYELINIZATION; SAMPLE SIZE; TREATMENT RESPONSE; WHITE MATTER LESION;

EID: 84892785199     PISSN: 22110348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msard.2013.09.007     Document Type: Article

References (31)

1. F. Barkhof, W. Bruck, C.J.A. De Groot, E. Bergers, S. Hulshof, and J. Geurts et al. Remyelinated lesions in multiple sclerosis - magnetic resonance image appearance Archives of Neurology 60 8 2003 1073 1081
2. T. Button, D. Altmann, D. Tozer, C. Dalton, K. Hunter, and A. Compston et al. Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab Multiple Sclerosis Journal 19 2 2013 241 244
3. R.A. Brown, S. Narayanan, and D.L. Arnold Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis Neuroimage 66 2013 103 109
4. L. Bo, C.A. Vedeler, H.I. Nyland, B.D. Trapp, and S.J. Mork Subpial demyelination in the cerebral cortex of multiple sclerosis patients Journal of Neuropathology and Experimental Neurology 62 7 2003 723 732
5. A Compston, and A. Coles Multiple sclerosis Lancet 372 9648 2008 1502 1517
6. P. Connick, M. Kolappan, C. Crawley, D.J. Webber, R. Patani, and A.W. Michell et al. Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study Lancet Neurology 11 2 2012 150 156
7. J. Carpenter, and J. Bithell Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians Statistics in Medicine 19 9 2000 1141 1164
8. M. Cercignani, M.R. Symms, M. Ron, and G.J. Barker 3D MTR measurement: from 1.5 T to 3.0 T Neuroimage 31 1 2006 181 186
9. J.T. Chen, K. Easley, C. Schneider, K. Nakamura, G. Kidd, and A. Chang et al. Clinically feasible MTR is sensitive to cortical demyelination in MS Neurology 80 3 2013 246 252
10. J.T. Chen, T. Kuhlmann, G.H. Jansen, D.L. Collins, H.L. Atkins, and M.S. Freedman et al. Voxel-based analysis of the evolution of magnetization transfer ratio to quantify remyelination and demyelination with histopathological validation in a multiple sclerosis lesion Neuroimage 36 4 2007 1152 1158
11. G.R. Davies, D.R. Altmann, A. Hadjiprocopis, W. Rashid, D.T. Chard, and C.M. Griffin et al. Increasing normal-appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing-remitting multiple sclerosis Journal of Neurology 252 9 2005 1037 1044
12. A.K. Foote, and W.F. Blakemore Inflammation stimulates remyelination in areas of chronic demyelination Brain 128 2005 528 539
13. E. Fisher, J.C. Lee, K. Nakamura, and R.A. Rudick Gray matter atrophy in multiple sclerosis: a longitudinal study Annals of Neurology 64 3 2008 255 265
14. L.K. Fisniku, D.T. Chard, J.S. Jackson, V.M. Anderson, D.R. Altmann, and K.A. Miszkiel et al. Gray matter atrophy is related to long-term disability in multiple sclerosis Annals of Neurology 64 3 2008 247 254
15. L. Frison, and S.J. Pocock Repeated measures in clinical-trials - analysis using mean summary statistics and its implications for design Statistics in Medicine 11 13 1992 1685 1704
16. T. Goldschmidt, J. Antel, F.B. Koenig, W. Brueck, and T. Kuhlmann Remyelination capacity of the MS brain decreases with disease chronicity Neurology 72 22 2009 1914 1921
17. A. Kutzelnigg, C.F. Lucchinetti, C. Stadelmann, W. Bruck, H. Rauschka, and M. Bergmann et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 2005 2705 2712
18. C.F. Lucchinetti, B.F.G. Popescu, R.F. Bunyan, N.M. Moll, S.F. Roemer, and H. Lassmann et al. Inflammatory cortical demyelination in early multiple sclerosis New England Journal of Medicine 365 23 2011 2188 2197
19. S. Mesaros, M.A. Rocca, M.P. Sormani, P. Valsasina, C. Markowitz, and N. De Stefano et al. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study Multiple Sclerosis. 16 3 2010 325 331
20. J.W. Prineas, R.O. Barnard, E.E. Kwon, L.R. Sharer, and E.S. Cho Multiple-sclerosis - remyelination of nascent lesions Annals of Neurology 33 2 1993 137 151
21. M.A. Rocca, G. Mastronardo, M. Rodegher, G. Comi, and M. Filippi Long-term changes of magnetization transfer-derived measures from patients with relapsing-remitting and secondary progressive multiple sclerosis American Journal of Neuroradiology 20 5 1999 821 827
22. K. Schmierer, F. Scaravilli, D.R. Altmann, G.J. Barker, and D.H. Miller Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain Annals of Neurology 56 3 2004 407 415
23. K. Schmierer, C.A.M. Wheeler-Kingshott, P.A. Boulby, F. Scaravilli, D.R. Altmann, and G.J. Barker et al. Diffusion tensor imaging of post mortem multiple sclerosis brain Neuroimage 35 2 2007 467 477
24. K. Schmierer, D.J. Tozer, F. Scaravilli, D.R. Altmann, G.J. Barker, and P.S. Tofts et al. Quantitative magnetization transfer imaging in postmortem multiple sclerosis brain Journal of Magnetic Resonance Imaging 26 1 2007 41 51
25. K. Schmierer, F. Scaravilli, G.J. Barker, R. Gordon, D.G. MacManus, and D.H. Miller Stereotactic co-registration of magnetic resonance imaging and histopathology in post-mortem multiple sclerosis brain Neuropathology and Applied Neurobiology 29 6 2003 596 601
26. M.P. Sanfilipo, R.H.B. Benedict, J. Sharma, B. Weinstock-Guttman, and R. Bakshi The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction Neuroimage 26 4 2005 1068 1077
27. E.C. Tallantyre, L. Bo, O. Al-Rawashdeh, T. Owens, C.H. Polman, and J. Lowe et al. Greater loss of axons in primary progressive multiple sclerosis plaques compared to secondary progressive disease Brain 132 2009 1190 1199
28. S.A. Trip, P.G. Schlottmann, S.J. Jones, D.R. Altmann, D.F. Garway-Heath, and A.J. Thompson et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis Annals of Neurology 58 3 2005 383 391
29. I.J. Van den Elskamp, D.L. Knol, H. Vrenken, G. Karas, A. Meijerman, and M. Filippi et al. Lesional magnetization transfer ratio: a feasible outcome for remyelinating treatment trials in multiple sclerosis Multiple Sclerosis Journal 16 6 2010 660 669
30. J. Van Waesberghe, W. Kamphorst, C.J.A. De Groot, M.A.A. van Walderveen, J.A. Castelijns, and R. Ravid et al. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability Annals of Neurology 46 5 1999 747 754
31. E.T. Wood, I. Ronen, A. Techawiboonwong, C.K. Jones, P.B. Barker, and P. Calabresi et al. Investigating axonal damage in multiple sclerosis by diffusion tensor spectroscopy Journal of Neuroscience 32 19 2012 6665 6669